AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06405373 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ReCharge
Description: ReCharge is an emotions-focused intervention that utilizes core components of Acceptance and Commitment Therapy (ACT) to address and minimize diabetes distress. This 5-week, group-based, virtual intervention will include a stepwise process to address diabetes distress and provide opportunities to practice new skills. Weekly assignments between the sessions will reinforce class material and give additional practice opportunities. Participants will be expected to interact in each session and will have opportunities to share their experiences and be engaged in discussion with the group and the facilitator.
Study NCT06405373 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TakeCharge
Description: TakeCharge is a problem-solving focused intervention that empowers participants to identify and make meaningful changes in their blood glucose management and other diabetes-related behaviors. This 5-week, group-based, virtual intervention will include a stepwise process to analyze data and resolve challenging situations surrounding diabetes management and provide opportunities to practice new skills. Weekly assignments between the sessions will reinforce class material and give additional practice opportunities. Participants will be expected to interact in each session and will have opportunities to share their experiences and be engaged in discussion with the group and the facilitator.
Study NCT06448871 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound assessment of the right lower extremity muscles
Description: Rectus femoris cross sectional area (RFCSA), RF muscle thickness, vastus lateralis (VL) muscle thickness, Gastrocnemius medialis (GM) muscle thickness, VL pennation angle (PA), and GM PA.
Study NCT06448871 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Dual-energy X-ray absorptiometry (DXA) scan
Description: skeletal muscle mass (SM), appendicular skeletal muscle mass index (ASMI), total lean body mass (LBM), total fat mass (BF), percentage fat mass, and fat mass index (FMI).
Study NCT04956393 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Immediate 8-Week SOAR Program
Description: This is an 8-week, virtually delivered, exercise-based, knee health program delivered to knee injury participants by trained physiotherapists. The program has 3 components:~1. Knee Camp: This includes an interactive education session about knee health, 1:1 knee exam, and 1:1 counseling session to identify Specific, Measurable, Attainable, Relevant, and Time-bound (SMART) weekly home-based exercise-therapy and physical activity goals, Participants are asked to wear Fitbit's® 24-hours/day.~2. Weekly Home-based Exercise-Therapy and Physical Activity, with Tracking: At home, participants work to meet their exercise-therapy and physical activity goals. Exercises are tracked with an online bespoke form and activity, with a Fitbit.~3. Weekly PT-guided Exercise-Therapy and Physical Activity Counseling Sessions: Each week participants will attend a 1:1 virtual physiotherapist counseling session to modify SMART goals and have the option to attend a group exercise class.
Study NCT04956393 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Delayed 8-Week SOAR Program
Description: This is an 8-week, virtually delivered, exercise-based, knee health program delivered to knee injury participants by trained physiotherapists. The program has 3 components:~1. Knee Camp: This includes an interactive education session about knee health, 1:1 knee exam, and 1:1 counseling session to identify Specific, Measurable, Attainable, Relevant, and Time-bound (SMART) weekly home-based exercise-therapy and physical activity goals, Participants are asked to wear Fitbit's® 24-hours/day.~2. Weekly Home-based Exercise-Therapy and Physical Activity, with Tracking: At home, participants work to meet their exercise-therapy and physical activity goals. Exercises are tracked with an online bespoke form and activity, with a Fitbit.~3. Weekly PT-guided Exercise-Therapy and Physical Activity Counseling Sessions: Each week participants will attend a 1:1 virtual physiotherapist counseling session to modify SMART goals and have the option to attend a group exercise class.
Study NCT06193421 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ambroxol Hydrochloride
Description: 75mg slow release (SR), X16/day or 300mg X4/day oral capsules.
Study NCT05178082 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational Video-based Pain Program
Description: Educational videos with 10 modules with information about pain.
Study NCT06549842 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Terumo Radial Band
Description: Group 1 will receive TR band post cardiac catheterization for radial hemostasis.
Study NCT06549842 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vaosband
Description: Group 2 will receive Vasoband post cardiac catheterization for radial hemostasis.
Study NCT05302531 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Description: Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally
Study NCT05302531 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Description: Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally
Study NCT05302531 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ofloxacin
Description: Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally
Study NCT05302531 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole trimethoprim
Description: Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally
Study NCT05430243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 MG
Description: once daily empagliflozin 10mg+/- diuretics
Study NCT05430243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diuretics
Description: diuretics as clinically indicated
Study NCT05430243 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diuretics
Description: diuretics as clinically indicated
Study NCT05418881 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Mobile Tracking Device (one spot)
Description: Patients will be fitted with 4 different tracking devices (Garmin Fenix 6 Pro®, Apple Watch 7®, FitBit Sense®, Withings ScanWatch®).
Study NCT05178082 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Empowered Relief Program
Description: Educational online session for skills acquisition to manage pain. Empowered Relief TM by Beth Darnall ©2013-2022 Stanford University
Study NCT05418881 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Mobile Tracking Device + Activity Sensor (longitudinal)
Description: Patients will be fitted with 1 of 3 different tracking devices (Garmin Fenix 6 Pro®, Apple Watch 7®, Withings ScanWatch®). The type of tracking device will be randomized. Additionally an Activity Tracker and one-channel ECG (Movesense®) will be worn by the patients.
Study NCT04742400 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tolebrutinib 60mg
Description: 60 mg orally
Study NCT05057429 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Procellera Bioelectric Dressing
Description: Procellera is single layer, broad-spectrum antimicrobial wound dressing. Embedded in the dressing are microcell batteries made of elemental silver and zinc applied in a dot-matrix pattern. The bioelectric dressing will be applied to surgical site wound with a hydrogel.
Study NCT05057429 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Gauze Dressing
Description: Standard of care non-adherent gauze dressing will be applied to surgical site with vaseline.
Study NCT05162820 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 100 mg Solarplast
Description: 100 mg Solarplast delivered in capsules with the carrier of rice dextrin and medium chain triglycerides consumed daily at breakfast for 60 days
Study NCT05162820 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: rice dextrin and medium chain triglycerides in capsules consumed daily at breakfast for 60 days
Study NCT05553691 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPL026
Description: Intravenous
Study NCT04683887 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tape application
Description: Application of the tape with lymphatic technique to the fingers, both dorsally and volarly, of wrist fractured patients treated with a forearm cast
Study NCT05373433 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SSD8432 750mg
Description: Experimental group:SSD8432 750mg and Ritonavir 100mg, Day1--Day5,BID
Study NCT05373433 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SSD8432 placebo
Description: Control group :SSD8432 placebo and Ritonavir placebo, Day1--Day5,BID
Study NCT05802095 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Supplemental Feeding Tube Device
Description: One end of the catheter is in such a way that milk comes into the bottle. The tip of the feeding catheter can be fixed to the mother's breast with a plaster so that it is in the baby's mouth. The tip of the catheter is placed inside the baby's mouth while the baby is sucking on its mother. While the mother is breastfeeding, milk is supplied to the baby from both the mother and the bottle. The baby will continue to suckle as he feels that plenty of milk is coming. To increase the flow of milk from the bottle, the mother hangs the bottle around her neck with the teat side down. The higher the bottle or milk container is held, the greater the flow of milk. It is an easy and safe method.
Study NCT06452433 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gumarontinib
Description: 300 mg , qd ,po, expect 6 months.
Study NCT06452433 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: third-generation EGFR-TKI (Osimertinib, Almonertinib or Furmonertinib)
Description: According to the actual situation of patients. Take as recommended, expect 6 months.
Study NCT05765929 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-operative treatment
Description: Patients will be treated with a walker-orthosis for 6 weeks. Weightbearing as tolerated
Study NCT04340700 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: THC or Placebo
Description: A standard dose of THC (8 mg or 2 mg) will be placed in a Volcano Vaporizer chamber. The first THC dose is 8 mg, followed by approximately three doses of 2 mg each. Placebo will also be administered through a Volcano Vaporizer via inhalation. The first placebo dose is 8 mg, followed by approximately three doses of 2 mg each to match the THC procedures.
Study NCT04340700 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: THC or Placebo
Description: A standard dose of THC (8 mg or 2 mg) will be placed in a Volcano Vaporizer chamber. The first THC dose is 8 mg, followed by approximately three doses of 2 mg each. Placebo will also be administered through a Volcano Vaporizer via inhalation. The first placebo dose is 8 mg, followed by approximately three doses of 2 mg each to match the THC procedures.
Study NCT04742400 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tolebrutinib 120mg
Description: 120 mg orally
Study NCT05692752 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Expression of miR-133a \&208b at 4, 8, 12, 24 and 48 hours from the first appearance of myocardial infarction (MI) symptoms
Study NCT05031871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR17031 injection ；INS068 injection；SHR20004 injection
Description: HR17031 injection dose+INS068 injection dose+SHR20004 injection dose+(INS068+SHR20004) injection dose
Study NCT05031871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR17031 injection ；INS068 injection；SHR20004 injection
Description: INS068 injection dose+(INS068+SHR20004)injection dose+ HR17031 injection dose +SHR20004 injection dose
Study NCT05031871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR17031 injection ；INS068 injection；SHR20004 injection
Description: SHR20004 injection dose+ HR17031 injection dose +(INS 068+SHR20004) injection dose+ INS068 injection dose
Study NCT05031871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR17031 injection ；INS068 injection；SHR20004 injection
Description: (INS 068+SHR20004) injection dose+ SHR20004 injection dose+ INS068 injection dose+ HR17031 injection dose
Study NCT05543070 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Low-dose radiotherapy
Description: Electron Beam/3D-CRT/IMRT/VMAT
Study NCT06522516 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Evidence-based caregiving training
Description: This is designed based on evidence of daily living activity ability caregiving, including① Dietary training: guiding caregivers to choose appropriate tableware according to the functional status of disabled elderly people, and training them in eating posture such as changing positions and using tableware; ② Dressing training: guide caregivers to train disabled elderly people on how to put on and take off clothes, shoes, socks, etc.; ③ Personal hygiene training: including washing face, hands, brushing teeth, etc.; ④ Excretion function training: including urination function training and defecation function training; ⑤ Mobile training: including support walking training, cane walking training, etc.; ⑥ Wheelchair training: Guide caregivers to use wheelchairs according to the specific situation of disabled elderly people.
Study NCT06522516 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: family resilience intervention
Description: The intervention will be developed based on the Maccubbin Family Resilience Theory, and Delphi methods. The content will contain 8 topics and be incorporated into caregiving training manual.
Study NCT06522516 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: usual service
Description: This means the usual service provided by the local community health center from nurses during bi-weekly home visit.
Study NCT06522516 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: usual service
Description: This means the usual service provided by the local community health center from nurses during bi-weekly home visit.
Study NCT06311539 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Theraband Strengthening Exercise Program
Description: Resisted knee flexion in prone position and resisted knee extension in seated position (for dominant leg) and bilateral squats were practiced in 3 sets of 12 repetitions. Participants rested for 30 seconds between sets. The program, which lasted approximately 30 minutes in total, continued for a total of 6 weeks, the first 3 weeks with the red theraband and the last 3 weeks with the black theraband.~15 morning type participants will be included in the morning exercise program (08:00) and 15 morning type participants will be included in the evening exercise program (18:00).~15 evening type participants will be included in the morning exercise program (08:00) and 15 evening type participants will be included in the evening exercise program (18:00).
Study NCT05469321 — intervention group
Intervention type: OTHER
Intervention: None, pure observationnal study
Description: None, pure observational study following the usual management of the patients
Study NCT03921164 — intervention group
Intervention type: PROCEDURE
Intervention: Trans-oesophageal Doppler
Description: As required by the standard of care of the interventional neuroradiology procedure, the neuroradiologist also cannulates the femoral artery. At the end of the procedure, during catheter withdrawal, pressure waveforms are recorded in the descending thoracic aorta just in front of the esophageal Doppler probe.~Descending aortic velocity is measured with a transesophageal Doppler CardioQ-ODM+ (Deltex Medical, Chichester, UK) in order to construct the VP Loop in descending thoracic aorta.
Study NCT05719610 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cawthorne Cooksey Exercises for Balance Training
Description: Group of Exercises used to Increase balance
Study NCT05719610 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Swiss Ball Exercises
Description: Swiss Ball Exercises
Study NCT06129487 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Narrative pictorial warning labels for alcoholic beverages
Description: Pictorial warning labels consisting of text and narrative imagery (e.g., photos of cancer patients) conveying the risk of alcohol for oral cancer, esophageal cancer, and larynx cancer.
Study NCT06129487 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Non-narrative pictorial warning labels for alcoholic beverages
Description: Pictorial warning labels consisting of text and non-narrative imagery (e.g., images of diseased organs) conveying the risk of alcohol for oral cancer, esophageal cancer, and larynx cancer.
Study NCT06276179 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxycodone
Description: Patient will receive a bolus dose of 0.15 mg/kg plus 20 ml bupivacaine 0.25% followed by an infusion 0.03 mg/kg/h oxycodone plus 0.1 mL/Kg/h bupivacaine 0.125%.
Study NCT06276179 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: Patient will receive a bolus 20 ml bupivacaine 0.25% followed by an infusion 0.1 mL/Kg/h bupivacaine 0.125%.
Study NCT05549128 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Photobiomodulation
Description: The red laser (DMC) will be applied with the aim of reducing the anxiety of children during the dental consultation. It will be continuously and directly with 60J of energy, wavelength of 660nm and 100mW/cm2 of power. The application will be located in the unilateral radial artery for 10 minutes. The laser will be transmitted through an appropriate bracelet where the laser tip fits perfectly. It is a painless, non-invasive method that does not cause any discomfort during application.
Study NCT05549128 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Photobiomodulation sham
Description: The red laser (DMC) will be applied off. I
Study NCT06370195 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Comprehensive rehabilitation
Description: The study lasted 10d for each patient. During the treatment, All the participants were provided with the rehabilitation therapy, which included routine rehabilitation, cognitive training, swallowing function training.
Study NCT06370195 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Comprehensive rehabilitation
Description: The study lasted 10d for each patient. During the treatment, All the participants were provided with the rehabilitation therapy, which included routine rehabilitation, cognitive training, swallowing function training.
Study NCT06370195 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stellate ganglion block
Description: Based on the invention above, the patients in the observation group were provided with Stellate ganglion block , using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g). The percutaneous approach via the paratracheal route was used for Stellate ganglion block . The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT06370195 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride
Description: Based on the invention above, the patients in the observation group were provided with Stellate ganglion block , using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g). The percutaneous approach via the paratracheal route was used for Stellate ganglion block . The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT06370195 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo injection
Description: 1 milliliter of normal saline will be used for injection. The percutaneous approach via the paratracheal route was used for Stellate ganglion block . The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT05882981 — intervention group
Intervention type: OTHER
Intervention: Sit and reach test
Description: It will be used to measure the flexibility of the participants.
Study NCT05882981 — intervention group
Intervention type: OTHER
Intervention: Hand grip strength measurement
Description: Grip strength will be evaluated with a hand dynamometer in the position recommended by the American Association of Hand Therapists.
Study NCT05882981 — intervention group
Intervention type: OTHER
Intervention: Back-leg-chest muscle strength measurement
Description: An analog Back Leg-Chest dynamometer will be used to evaluate general muscle strength.
Study NCT05882981 — intervention group
Intervention type: OTHER
Intervention: Functional performance
Description: Single-leg and double-leg horizontal jump test will be used to evaluate lower extremity functional performance. The tests will be carried out according to the Eurofit test battery (Council of Europe, 1988).
Study NCT05882981 — intervention group
Intervention type: OTHER
Intervention: Functional capacity
Description: Functional capacity will be evaluated with six minute walk test according to the ATS criteria.